Article
RNA-based vaccines and innate immune activation: Not too hot and not too cold
12 Mar 2021
Abstract excerpt
RNA-based vaccine technology received a significant boost this past year with the approval of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines developed by Biotech/Pfizer and Moderna. In addition to such mRNA-based vaccines, self-amplifying RNA (sa-RNA) can also be used for vaccination.1 In addition to the transgene product, the sa-mRNA encodes an RNA-dependent RNA polymerase, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
